Phosphoinositide 3-kinase (PI3K) describes a family of enzymes required for a variety of cellular functions. PI3K pathways are important for processes, including cellular growth, proliferation, differentiation, and intracellular trafficking.
Learning Objectives: 1. Understand how the outcome of PD-1 blockade is a summation of increased Teffector activity and increased Treg suppressive activity 2. Explain how PD-1 blockade leads...
Activating mutations in PIK3CA are frequent in human breast cancer, and phosphoinositide 3-kinase alpha (PI3Kα) inhibitors have been approved for therapy. To characterize determinants...
Combinatorial inhibition of effector and feedback pathways is a promising treatment strategy for KRAS mutant cancers. However, the particular pathways that should be targeted to optimize the...
On measuring photons and ions: Impact on panel design, signal detection and data quality 10:30–11:00 am PDT Presented By: Tim Bushnell, PhD, MBA Monitoring immunotherapy with a mass cy...
With over 200 validated antibodies and the option to add custom antibodies, the GeoMx DSP protein portfolio offers options to fit a wide range of spatial profiling application needs. NanoStr...
Learning Objectives: 1. Understand how the outcome of PD-1 blockade is a summation of increased Teffector activity and increased Treg suppressive activity 2. Explain how PD-1 blockade leads...
Activating mutations in PIK3CA are frequent in human breast cancer, and phosphoinositide 3-kinase alpha (PI3Kα) inhibitors have been approved for therapy. To characterize determinants...
Combinatorial inhibition of effector and feedback pathways is a promising treatment strategy for KRAS mutant cancers. However, the particular pathways that should be targeted to optimize the...
On measuring photons and ions: Impact on panel design, signal detection and data quality 10:30–11:00 am PDT Presented By: Tim Bushnell, PhD, MBA Monitoring immunotherapy with a mass cy...
With over 200 validated antibodies and the option to add custom antibodies, the GeoMx DSP protein portfolio offers options to fit a wide range of spatial profiling application needs. NanoStr...
DATE: January 25, 2018TIME: 8:00AM PST, 10:00AM CSTProstate cancer (PCa) is the most common noncutaneous malignancy in men in the US. A significant fraction of advanced PCa treate...
DATE: January 26th, 2016
TIME: 8am pacific, 11am eastern
PTEN gene loss occurs frequently in castration-resistant prostate cancer (CRPC) and may drive progression through activation of th...
Patients with chromosomal rearrangements resulting in fusion proteins are among the most responsive to published targeted therapy. For example, targeting of the EML4-ALK fusion in non-small c...
Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-oncology is considered by some to be...
LabRoots and the Cancer Research and Oncology Planning Committee are pleased to announce the 8th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
Labroots invites you to the 3rd Annual Event in the CRISPR Virtual Event Series! This follow up event to a very popular first-year event will continue the...
Please join us at the 9th Annual Fluidigm Mass Cytometry Virtual Summit This yearly international meeting of the mass cytometry community is designed for new and experienced users, as well a...
New technologies are enabling discoveries that advance our understanding of how tumors develop, evade the immune system, and progress. This virtual conference brings together research profes...
Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-oncology is considered by some to be...
LabRoots and the Cancer Research and Oncology Planning Committee are pleased to announce the 8th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
Labroots invites you to the 3rd Annual Event in the CRISPR Virtual Event Series! This follow up event to a very popular first-year event will continue the...
Please join us at the 9th Annual Fluidigm Mass Cytometry Virtual Summit This yearly international meeting of the mass cytometry community is designed for new and experienced users, as well a...
New technologies are enabling discoveries that advance our understanding of how tumors develop, evade the immune system, and progress. This virtual conference brings together research profes...
This event will highlight the innovative use of big data to inform cancer drug development and transform cancer clinical development. The wealth of curated and well-annotated cancer genomic...